Subscribe To
CHNXF / ChitogenX raises $3.9M to advance tissue repair research
CHNXF News
By Proactive Investors
September 29, 2023
ChitogenX ends 2Q with stronger balance sheet as it advances its flagship ORTHO-R platform
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) told investors that it made significant progress in deleveraging its balance sheet and improving its working cap more_horizontal
By Proactive Investors
September 28, 2023
ChitogenX receives notice of allowance for key patent in the US and Canada
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) told investors it has received a notice of allowance for a key patent in the US and Canada. The company noted th more_horizontal
By Proactive Investors
September 26, 2023
ChitogenX concludes enrolment for its US Phase I/II rotator cuff tear repair clinical trial
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) said it has concluded the enrolment of 20 subjects in its US multi-site rotator cuff tear repair Phase I/II clin more_horizontal
By Proactive Investors
June 30, 2023
ChitogenX reports first quarter results, highlights milestone in rotator cuff repair Phase I/II trial
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) has noted that patient recruitment for its rotator cuff repair Phase I/II trial reached an important milestone� more_horizontal
By Proactive Investors
June 15, 2023
ChitogenX pursuing new strategic development partnerships
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) said it has partnered with Bruder Consulting & Venture Group (BCVG) as its exclusive advisory firm for the pur more_horizontal
By Proactive Investors
May 5, 2023
ChitogenX raises $3.9M to advance tissue repair research
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) said it has closed its amended non-brokered private placement offering for gross proceeds of $3.86 million. The more_horizontal
By Proactive Investors
April 4, 2023
ChitogenX announces non-brokered private placement for gross proceeds of $2.5M
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) has announced a non-brokered private placement offering of 12,500,000 units at a price of $0.20 each for gross p more_horizontal
By Proactive Investors
February 16, 2023
ChitogenX obtains $3,472,000 grant from The Natural Sciences and Engineering Research Council of Canada (NSERC) and Prima Québec
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) said it has obtained, in partnership with Polytechnique Montréal, a $3,472,000 grant from The Natural Sciences more_horizontal